'We are very pleased that Bill has decided to return to Baird to continue his career', said Steve Booth, Baird COO and Director of Investment Banking. 'He is a skilled M&A professional with more than 20 years of investment banking experience and extensive knowledge of Healthcare IT and Services'.
Brian Doyal, Head of Baird’s Healthcare and Services Investment Banking teams, added: 'Bill’s strong track record in the Healthcare IT and Services sector will be a great complement to the expertise of Baird’s other senior Healthcare bankers'.
Suddath returns to Baird from Leerink Swann where he led their Healthcare IT and Specialty Healthcare Services franchise. He joined Baird in 2007 as a Managing Director where he was instrumental in establishing and growing the firm’s Healthcare Services banking effort. Prior to Baird, Suddath spent several years at JP Morgan/Hambrecht & Quist.
With nearly 20 investment bankers, Baird’s Healthcare Investment Banking team generated great client outcomes and record results for the firm in 2011 and 2012. Healthcare remains a key area of focus at Baird as evidenced by recent additions to its Healthcare Capital Markets, Sales, Trading and Advisory teams. Last month, Baird added Brian Skorney as a Senior Analyst in equity research to join fellow Senior Analyst Chris Raymond in covering Biotechnology stocks. In August, David Schechner joined Baird’s Healthcare investment banking team as a Managing Director.
'Continuing to build Baird’s Healthcare franchise is a strategic priority for the firm, and we are excited by the recent additions to our banking and research teams', said Doyal.